News Novartis drug effective in advanced MS Siponimod slowed disability progression in secondary progressive multiple sclerosis
Views & Analysis After 2015's ‘breakthrough’ year for pharma approvals, will ... Roche's MS drug is among major drugs still to come in 2016.
News Scangos to leave Biogen at a crossroads Company has grown, but direction towards next stage is unclear